baber/WOPTO huggingface dataset:
Patent JP-H0642279-B2 (JP)
IPC: H04Q9/00
Filed: 1986-02-18
Abstract: An automatic/remote instrument monitoring system and method are disclosed. RF transponder units are operatively connected to and monitor one or more parameters of a remotely located instrument. The transponders include RF receivers that sample received RF signals at a low duty cycle and look for a common wake-up signal transmitted from a mobile data collection unit. All transponders receiving the common wake-up signal simultaneously energize their respective transmitters and transmit their respective messages over a predetermined RF transmission bandwidth to receivers in the mobile unit. The time and frequency parameters of the transponder transmissions are varied in a manner such that the transmission signals of simultaneously transmitting transponders differ. A plurality of RF receivers in the mobile unit are respectively tuned to collectively receive the transponder transmissions, across the entire transmission bandwidth. Decoding and signal processing circuits in the mobile receiver unit identify transmitting transponders and process their respective messages.
Patent JP-3608572-B2 (JP)
IPC: C07K19/00
Filed: 1989-12-20
Granted: 2005-01-12
Abstract: Methods are provided for the preparation in recombinant host cells of biologically active soluble variants of discretely encoded, heteromultimer polypeptide receptors. Such variants are synthesized by the secretion from recombinant transformants of transmembrane-modified heteromultimer receptors. Preferred receptors are extracellular matrix, cell surface, or plasma protein-binding receptors such as GPIIb-IIIa.
Patent JP-H0667856-B2 (JP)
IPC: C07D307/33
Filed: 1987-06-22
Abstract: PCT No. PCT/FR87/00238 Sec. 371 Date Apr. 1, 1988 Sec. 102(e) Date Apr. 1, 1988 PCT Filed Jun. 22, 1987 PCT Pub. No. WO87/07889 PCT Pub. Date Dec. 30, 1987.The asymmetric hydrogenation of carbonyl compounds is carried out in the presence of at least one transition metal complex MZq(M=metal of group VIII of the Periodic Classication; Z=ligand selected among the atoms and the molecules which may complex the metal M; and q=degree of corrdination of M) and of at least one chiral phosphorous-containing ligand having formula (I), wherein R is hydrocarbonated radical (alkyl, cycloalkyl and aryl); R1 is H, hydrocarbonated radical or PR2; R2 is H or hydrocarbonated radical R3,R4, necessarily different, are H and optionally functionalized hydrocarbonated radicals; R5 and R6 are H and optionally functionalized hydrocarbonated radicals; one of the radicals R3 and R4 possibly carrying a function - OPR2 or NPR2, R5 and R6 being in this case H when R1 is PR2; R2 and R3 and the atoms of N and C which cary them respectively forming a heterocycle; or R2 and R5, the atoms of N and C which carry them respectively and the intermediate C atom possibly forming a heterocycle.    <IMAGE> (I)
Patent JP-2779191-B2 (JP)
IPC: C12N1/20
Filed: 1988-05-24
Granted: 1998-07-23
Abstract: Production of ethanol by a process in which a strain of Bacillus stearothermophilus or other thermophilic, facultatively anaerrobic bacterium is selected for the characteristics of fermenting sugars both aerobically and anaerobically and of being active in anaerobic fermentation at 70 DEG C or above and (i) anaerobic fermentation is carried out with continuing removal of ethanol at 70 DEG C or above; (ii) the fermentative activity of the bacterium is maintained by withdrawing a proportion of the anaerobic fermentation medium on a continuing basis preferably with removal of ethanol and allowing the bacteria therein to multiply aerobically, using residual sugars or metabolites thereof present in the medium, before being returned to the anaerobic fermentation.
Patent JP-2515870-B2 (JP)
IPC: C10J/
Filed: 1988-05-27
Granted: 1996-07-10
Abstract: A process for the transformation of combustible pollutants or waste materials into clean energy and utilisable products, characterised by: - submitting the material to be treated to the action of a thermic lance in an airless atmosphere so as to totally decompose it and extract combustible gases, non-combustible gases and inerts, - cooling the thermally decomposed products and separating the inert products with water, thus generating steam, - introducing the steam and said cooled gases onto a heated carbonaceous mass in order to filter the gases and, in part, transform them to obtain hydrogen, carbon monoxide and other totally utilisable gaseous products, and - cooling said gaseous products. a
Patent JP-3403403-B2 (JP)
IPC: C12N15/12
Filed: 1991-03-22
Granted: 2003-05-06
Abstract: A cDNA of a mouse G-CSF receptor is cloned from a library of cDNAs originating in mouse myeloid leukemia cells to analyze its structure. Further, by using this cDNA as the probe, a cDNA of a human G-CSF receptor is cloned from a library of cDNAs originating in human placental or human histocytic lymphoma cells to analyze its structure and at the same time introduce it into a host cell to effect expression. As a result of this expression, it now becomes possible to stably supply a G-CSF receptor useful in both basic research and clinical application. <IMAGE>
Patent JP-3045314-B2 (JP)
IPC: C07D303/04
Filed: 1991-12-17
Granted: 2000-05-29
Abstract: Disclosed is a novel process for the preparation of epoxyalkanes and epoxycycloalkanes which comprises hydrogenating  gamma , delta -epoxyalkenes or  gamma , delta -epoxycycloalkenes in the presence of a rhodium catalyst. The process is especially useful for the preparation of 1,2-epoxybutane from 3,4-epoxy-1-butene.
Patent JP-3492373-B2 (JP)
IPC: C07K19/00
Filed: 1994-08-19
Granted: 2004-02-03
Abstract: PCT No. PCT/GB94/01816 Sec. 371 Date Feb. 23, 1996 Sec. 102(e) Date Feb. 23, 1996 PCT Filed Aug. 19, 1994 PCT Pub. No. WO95/06067 PCT Pub. Date Mar. 2, 1995A molecule which (i) binds human membrane-bound carcinoembryonic antigen, (ii) binds a hybrid polypeptide consisting of residues 1 to 314 of human biliary glycoprotein joined (N-C) to residues 490 to C-terminus of human carcino embryonic antigen, but (iii) does not bind to human biliary glycoprotein excluding an intact mouse monoclonal antibody comprising an IgG group IIA heavy chain and a kappa group V light chain wherein the sequence of the VH chain is QVKLQQSGPELKKPGETVKISCKASGYTFTVFGMNWVKQAPGKGLKWMGWIN-TKTGEATYVEEFKGRFAFSLETSATTAYLQINNLKNEDTAKYFCARWDFYDYVEAMDYWGQGTTVTVSS, or wherein the sequence of the VH chain is as given immediately above but the first amino acid residue of the VH CDR1 is glutamine and in either case the sequence of the VL chain is GDIVMTQSQRFMSTSVGDRVSVTCKASQNVGTNVAWYQQKPGQSPKALIYSASYRYSGVPDRFTGSG-SGTDFTLTISNVQSEDLAEYFCHQYYTYPLFTFGSGTKLEMKR. Preferably the molecule is a monoclonal antibody.
Patent JP-3485567-B2 (JP)
IPC: A61K31/4418
Filed: 1993-09-13
Granted: 2004-01-13
Abstract: PCT No. PCT/DK93/00291 Sec. 371 Date Mar. 15, 1995 Sec. 102(e) Date Mar. 15, 1995 PCT Filed Sep. 13, 1993 PCT Pub. No. WO94/06770 PCT Pub. Date Mar. 31, 1994The present invention relates to hitherto unknown compounds of formula or their tautomeric forms, the attachment to the pyridine ring being in the 3- or 4-position, in which R', R'' are the same or different and stand for hydrogen, halogen, or trifluoromethyl, hydroxy, C1-C4 alkyl or alkoxy, nitro, or cyano groups. Alkylene stands for a straight or branched C1-C8 carbon chain, which may be substituted by hydroxy or halogen, nitro or cyano groups. X stands for oxygen, for -S(O)n- where n stands for an integer from 0 to 2, or for =N-R1 where R1 is hydrogen or C1-C4 alkyl. R stands for hydrogen or for one or more C1-C4 alkyl or alkoxy, hydroxy, halogen, trifluoromethyl, cyano, carboxamido, sulfamoyl or nitro radicals. The present compounds are of value in the human and veterinary practice as selective serotonin receptor antagonists.
Patent JP-3717512-B2 (JP)
IPC: C07H15/04
Filed: 1993-10-22
Granted: 2005-11-16
Abstract: A shingoglycolipid represented by general formula (I), which is efficiacious even when administered in a small amount, is reduced in side effects, and has antitumor and immunopotentiating activities, wherein X and Y represent respectively integers of 10 to 24 and 9 to 13; R1 represents hexosyl, pentosyl, deoxyhexosyl, aminohexosyl, N-acetyl aminohexosyl, a halogenated derivative of any of them, or a sialic acid residue; R2 represents H or OR2', wherein R2' represents H, galactosyl or glucosyl; R3 represents H or OR3', wherein R3' represents H, galactosyl or glucosyl; R4 represents galactosyl or H; R5 represents methyl or isopropyl; and R6 and R7 represent each independently H or alternatively they are combined together to represent a double bond between the carbon atoms to which they are respectively bonded; provided that the case where R1 represents alpha -galactosyl and R4 represents H is excepted. <CHEM>
Patent JP-2989004-B2 (JP)
IPC: G01L1/18
Filed: 1990-06-20
Granted: 1999-12-13
Abstract: A transducer having a plurality of sensing elements disposed in a single diaphragm wherein each of the sensing elements is spaced from every other of the sensing elements a predetermined distance so as to control interference among the sensing elements. Each of the sensing elements preferably comprises a plurality of piezoresistors each of which are coupled in a Wheatstone bridge configuration. This transducer achieves sensitive, accurate, high spatial resolution measurements of non-uniform pressures.
Patent JP-2810789-B2 (JP)
IPC: A47G27/02
Filed: 1993-11-15
Granted: 1998-10-15
Abstract: PCT No. PCT/SE93/00976 Sec. 371 Date Jun. 12, 1995 Sec. 102(e) Date Jun. 12, 1995 PCT Filed Nov. 15, 1993 PCT Pub. No. WO94/10888 PCT Pub. Date May 26, 1994A method for reusing loose, rejected or scrapped mats (1) of the type having a compact rubber-cloth backing (2) with a textile pile (3) incorporated therein, as well as a circumferential, pile-free backing edge portion (4, 4'), is disclosed. After optionally shaving off pile to produce the circumferential, pile-free backing edge portion, two such mats of essentially the same size, or one such mat and a pile-free rubber cloth of essentially the same size, are put together with the pile sides facing one another, or with the pile side facing the rubber cloth. Then, the edge portions (4, 4') are attached to one another throughout the entire circumference in an air-entrapping manner, whereby to obtain a mat especially suited for use on working sites or in industry.
Patent JP-3869854-B2 (JP)
IPC: F25J3/02
Filed: 1996-10-04
Granted: 2007-01-17
Abstract: A support structure that is either floatable or otherwise adapted to be disposed in an offshore location at least partially above sea level. A natural gas liquefaction system is located on or in the support structure and has a series of heat exchangers for cooling the natural gas in a countercurrent heat exchange relationship with a refrigerant. One or more compressors compress the refrigerant which is divided into two separate streams. Each stream is fed to a liquid expansion turbine where it is isentropically expanded. The expanded streams of refrigerant are then fed to the cool end of one of the heat exchangers.
Patent JP-H0556977-B2 (JP)
Inventor: NIEMINEN MATSUTEI OO JEI
IPC: A61G7/10
Filed: 1990-10-18
Abstract: PCT No. PCT/FI90/00244 Sec. 371 Date May 18, 1992 Sec. 102(e) Date May 18, 1992 PCT Filed Oct. 18, 1990 PCT Pub. No. WO91/05532 PCT Pub. Date May 2, 1991.In a hospital bed comprising a body (4) provided with wheels, a transfer underlay frame (24) for a patient, a lying or resting frame (17), which can be lifted and lowered down, lifting means (30) for the lying frame, and bearer means (15, 20) for a transfer underlay frame; the bearer means comprise two U-shaped bearer rods (15) disposed side by side and turnable in the body, the upper and the lower arms (15b, 15c) of which are interconnected through articulated joints (18, 22) by a transverse support (16, 21) so as to secure a parallel turn of the arms aside. A bearer beam (20) is secured to the upper transverse support (21) and wheels (19) to the lower support (16). The invention allows a sideways transfer of a patient on a transfer underlay supported by straps (26, 28) secured to a bearer beam, without changing the direction. Wheels (19) provided in the bearer rods (15) move simultaneously to the same direction which ensures that the bed (2) is properly supported during all stages of the transfer.
Patent JP-3450854-B2 (JP)
IPC: C07D235/26
Filed: 1993-03-08
Granted: 2003-09-29
Abstract: Antiviral nucleoside analogues contain a substituted benzimidazole base attached to a carbocyclic ring in place of the conventional sugar residue. Particularly preferred compounds include those in which the 2-, 5- and 6- positions of the benzimidazole base are substituted by halogen. The compounds have activity against herpes virus especially cytomegalovirus and also hepatitis B virus infections.
Patent JP-3553608-B2 (JP)
IPC: H02K3/48
Filed: 1996-10-16
Granted: 2004-08-11
Abstract: PCT No. PCT/EP96/04495 Sec. 371 Date Oct. 16, 1998 Sec. 102(e) Date Oct. 16, 1998 PCT Filed Oct. 16, 1996 PCT Pub. No. WO97/16881 PCT Pub. Date May 9, 1997The invention relates to a device for connecting to a grounding conductor the electrically conductive sheath of an electric lead laid in the slots of the inductor of a linear motor. The device is a metal shell (13), which encloses more than half the outer circumference of the lead (12) in the slot region, whose inside diameter is slightly smaller than the outside diameter of the lead (12), and which can be fastened in the respective slot (11) in a fashion lying against the inductor (10).
Patent JP-4451494-B2 (JP)
IPC: A61K31/20
Filed: 1994-12-06
Granted: 2010-04-14
Abstract: PCT No. PCT/EP94/04047 Sec. 371 Date Aug. 15, 1996 Sec. 102(e) Date Aug. 15, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/17188 PCT Pub. Date Jun. 29, 1995A drug for the release of active substances to the skin, which has an increased deuterium portion as compared to the natural isotope distribution.
Patent JP-2840132-B2 (JP)
IPC: A61K47/38
Filed: 1995-01-26
Granted: 1998-12-24
Abstract: PCT No. PCT/AT95/00014 Sec. 371 Date Jul. 12, 1996 Sec. 102(e) Date Jul. 12, 1996 PCT Filed Jan. 26, 1995 PCT Pub. No. WO95/20382 PCT Pub. Date Aug. 3, 1995A process for the production of S(+)-ibuprofen-particles having improved flow properties comprises the steps that coarse-crystalline S(+)-ibuprofen is molten and then in a molten condition is finely distributed in a non-solving medium, preferably in cold water, and is chilled therein. This chilling results in a fine-crystalline primary structure that agglomerates to a secondary structure. In this agglomerate form the product is obtained which is filtered out and is dried. Such particles are suitable for direct pressing of tablets, optionally, tableting auxiliary substances being added, also for the production of tablets having a retarded release of the active substance.
Patent JP-3963397-B2 (JP)
IPC: C09B29/50
Filed: 1995-12-05
Granted: 2007-08-22
Abstract: PCT No. PCT/GB95/02832 Sec. 371 Date Jul. 17, 1997 Sec. 102(e) Date Jul. 17, 1997 PCT Filed Dec. 5, 1995 PCT Pub. No. WO96/22333 PCT Pub. Date Jul. 25, 1996An azo pyrazolone compound of the formula: wherein Z represents a substituent selected from Cl, Br, F, NO2, SO2R, CO2R, NHSO2R1 and NHCOR1 in which R and R1 are hydrocarbyl groups and the sulphonic acid group in ring A is in the 3- or 4-position relative to the pyrazolyl group, said compound being in the form of a salt, and its use as a pigment.
Patent JP-3503066-B2 (JP)
IPC: A61K38/00
Filed: 1994-04-14
Granted: 2004-03-02
Abstract: PCT No. PCT/EP94/01154 Sec. 371 Date Dec. 26, 1995 Sec. 102(e) Date Dec. 26, 1995 PCT Filed Apr. 14, 1994 PCT Pub. No. WO94/26780 PCT Pub. Date Nov. 24, 1994Synthetic aglucodalbaheptides of formula (I) wherein W and Z, each independently, represent the relative portions of the aglycon of an antibiotic of the dalbaheptide group. Y represents a carboxylic group or a functional derivative of said carboxylic group; R and R1, each independently, represent hydrogen or a protecting group of the amino function. R2 represents hydrogen; and their salts with acid and bases as well as their inner salts. A process for producing the aglucodabaheptides of formula (I) and their use as medicaments.
Patent JP-3295941-B2 (JP)
IPC: G01N33/52
Filed: 1997-01-24
Granted: 2002-06-24
Abstract: PCT No. PCT/EP97/00337 Sec. 371 Date Jul. 24, 1998 Sec. 102(e) Date Jul. 24, 1998 PCT Filed Jan. 24, 1997 PCT Pub. No. WO97/27482 PCT Pub. Date Jul. 31, 1997The present invention provides methods and compositions relating to synthetic test stains comprising isolated fibrin and/or fibrin precursors and blood plasma proteins. Kits for the preparation of synthetic test stains containing an isolated fibrin precursor and an initiator for converting the fibrin precursor to fibrin are also provided. In addition, methods for checking the efficiency of cleaning processes, and kits for carrying out these methods are provided.
Patent JP-3996203-B2 (JP)
IPC: A61N1/30
Filed: 1997-12-09
Granted: 2007-10-24
Abstract: A novel electrotransport drug delivery system (10) and therapeutic agent-containing reservoir (26, 28) for use therein are provided. An inert filler material effective to reduce the quantity of therapeutic agent otherwise present is incorporated in the reservoir (26, 28) along with the therapeutic agent to be delivered via electrotransport. Methods for making the reservoir (26, 28) and drug delivery system (10) are provided as well.
Patent JP-4201843-B2 (JP)
IPC: H04N7/52
Filed: 1998-06-05
Granted: 2008-12-24
Abstract: An apparatus and a method for processing programs indicated by the associated program description to be audio-only programs, including the following. A respective program description for programs is received. Upon user selection of a program, a determination is made as to whether the selected program is an audio-only program. If the selected program is an audio-only program, then preprogrammed on-screen display information is displayed while the selected audio-only program is played to provide additional visual entertainment for users.
Patent JP-4090517-B2 (JP)
IPC: A61F2/30
Filed: 1999-01-27
Granted: 2008-05-28
Abstract: A spacer for insertion between two vertebrae has a variable axial length. The spacer comprises a first sleeve-shaped shape member 1 and a second member 2 which is slidably guided within the first member in axial direction relative thereto for adjusting the overall length. The second member 2 comprises, on its outer portion facing the first member 1, an axially extending portion having ratchet notch means 18, and the first member 1 has an engagement member 23 cooperating with the ratchet notch means 18 for displacement to a desired overall length.
Patent JP-3510637-B2 (JP)
IPC: A61C13/12
Filed: 1998-05-18
Granted: 2004-03-29
Abstract: The support for a dental prosthesis is symmetrical about a central axis (22). It has a bottom section (23) secured into the bone of the lower or upper jaw and an upper section to carry the crown, bridge etc. The upper section is shaped with radial ribs and slots to hold the crown in the selected angular setting. The top of the support has a sloping shoulder (37) to locate the lower edge of the crown. The gaps between the ridges are flat and at right angles to the axis of the support. The inside of the support has a blind hole threaded to take a fastener.
Patent ES-2346494-B2 (ES)
Title: Sensor en linea y sistema para la obtencion del contenido de grasa enleche.
Inventor: MUNIZ VEGA ROCIO
IPC: G01N21/35
Filed: 2007-11-20
Granted: 2011-07-21
Abstract: Sensor en línea y sistema para la obtención del
contenido de grasa en leche que son, respectivamente, un dispositivo
hueco similar a cualquier conducto por el que pueda fluir la leche y
que dispone de un orificio transparente a la luz y de una placa
situada a corta distancia y paralela a dicho orificio, de forma que
siempre haya leche en toda la sección que va desde el orificio hasta
esa placa; y un sistema capaz de producir la correspondiente luz de
excitación en el infrarrojo cercano o en el visible, por debajo de
1000 nm, y de recoger la señal de luz reflejada por la leche. El
contenido de la grasa se obtiene en el sistema en cada instante
aplicando un cálculo lineal simple o cuadrático y se proporciona
mediante señal analógica o digital, pudiendo suministrar también
acciones de control mediante salidas digitales. De aplicación en
instalaciones de producción lechera.
Patent ES-2350217-B2 (ES)
Title: Sistema para disipar la energia sismica en las construcciones.
Inventor: BENAVENT CLIMENT AMADEO
IPC: E04B1/98
Filed: 2009-04-17
Granted: 2011-08-31
Abstract: Sistema para disipar la energía sísmica en las
construcciones formado por dos o más perfiles, tubos o chapas
dispuestos con sus ejes en paralelo (1, 2), y conectados mediante
uno o más elementos disipadores de energía (3) dispuestos de forma
que sus ejes son perpendiculares a los ejes de los perfiles, tubos o
chapas. Los elementos disipadores de energía pueden ser perfiles,
preferentemente de sección transversal en I o H, que se hacen
trabajar de forma muy distinta a la usual cuando se emplean en
estructuras sismorresistentes: sometiendo el alma del perfil de
sección transversal en I o H a deformaciones plásticas de flexión en
un plano perpendicular al plano del alma, manteniendo las alas en
régimen elástico. Bajo solicitaciones axiles, la invención disipa
energía de forma estable sin pandear.
Patent ES-2385466-B2 (ES)
Title: Panel de acondicionamiento térmico cerámico.
Inventor: ECHARRI IRIBARREN VICTOR
IPC: E04B1/80
Filed: 2010-12-28
Granted: 2013-06-06
Abstract: Panel de acondicionamiento térmico cerámico para realizar acondicionamiento térmico de espacios por superficies radiantes en techos y paredes, que comprende una estructura multicapa que consiste en una pieza cerámica de gres porcelánico de bajo espesor y una trama capilar de tubos de polipropileno o cobre de pequeño diámetro conectada a tuberías de distribución de agua. Adicionalmente podemos incorporar una interfaz adhesiva para adherir la trama de tubos capilares de polipropileno o cobre a la pieza cerámica. Del mismo modo, este panel puede incluir una capa de aislamiento térmico (rígido o flexible según interese).#Existe la opción de realizar estos paneles con piezas de mayores dimensiones. La estructura del panel sería similar a la descrita anteriormente, pero seria necesario incluir un butiral adhesivo entre dos piezas cerámicas de gran formato.#Otra posible distribución sería utilizar piezas de gran formato pero descolgadas verticalmente.